LEUKEMIA, MYELOID
Clinical trials for LEUKEMIA, MYELOID explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, MYELOID trials appear
Sign up with your email to follow new studies for LEUKEMIA, MYELOID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune cell combo aims to stop leukemia relapse
Disease control Recruiting nowThis early-phase study tests whether giving specially trained immune cells (CIML NK cells) along with a targeted drug (venetoclax) can safely help prevent acute myeloid leukemia (AML) from coming back. Ten adults with AML who have already received standard treatment will receive …
Matched conditions: LEUKEMIA, MYELOID
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New transplant recipe aims to tame Graft-Versus-Host disease
Disease control Recruiting nowThis study tests a stem cell transplant using a reduced-intensity conditioning regimen (lower doses of chemotherapy and radiation) followed by a donor stem cell infusion. The goal is to treat various blood cancers and blood disorders while lowering the risk of graft-versus-host d…
Matched conditions: LEUKEMIA, MYELOID
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Supercharged immune cells aim to stop leukemia relapse
Disease control Recruiting nowThis early-phase trial tests whether specially trained natural killer (NK) cells, called CIML NK cells, along with interleukin-2 (IL-2), can safely prevent leukemia from coming back after a stem cell transplant. The study enrolls 15 adults with high-risk acute myeloid leukemia, m…
Matched conditions: LEUKEMIA, MYELOID
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug cocktail takes aim at Hard-to-Treat leukemia
Disease control Recruiting nowThis early-stage trial is testing a new drug called ziftomenib combined with standard chemotherapy or another targeted drug for people with relapsed or treatment-resistant acute myeloid leukemia (AML) that has specific genetic changes. The main goal is to see if these combination…
Matched conditions: LEUKEMIA, MYELOID
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New pill takes on tough blood cancers in first human trial
Disease control Recruiting nowThis early-phase trial tests an experimental oral drug called BH-30236 in adults with relapsed or refractory acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS). The study first tests BH-30236 alone, then in combination with another drug, venetoclax. About 17…
Matched conditions: LEUKEMIA, MYELOID
Phase: PHASE1 • Sponsor: BlossomHill Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC